<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03304483</url>
  </required_header>
  <id_info>
    <org_study_id>84542</org_study_id>
    <nct_id>NCT03304483</nct_id>
  </id_info>
  <brief_title>Cardiovascular Responses to Spartathlon Running</brief_title>
  <acronym>Spartathlon</acronym>
  <official_title>Cardiovascular Effects of Ultramarathon Running</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine the cardiovascular effects of ultramarathon running and
      their relation to performance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to determine the changes of cardiovascular morphology and
      function after an ultramarathon race. 50 entrants to the &quot;Spartathlon 2017&quot; 246-km running
      race will participate in the study. Cardiac and arterial morphology and function tests will
      be conducted one day before the race and within 20 minutes of race completion.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>athletes participating in the ultra marathon running</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Before and after the race</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change of right ventricular function after one day ultra-marathon running</measure>
    <time_frame>before and after 1 day running</time_frame>
    <description>Echocardiographic study of left ventricular function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of left ventricular function after one day ultra-marathon running</measure>
    <time_frame>before and after 1 day running</time_frame>
    <description>Echocardiographic study of left ventricular function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of carotid artery function after one day ultra-marathon running</measure>
    <time_frame>before and after 1 day running</time_frame>
    <description>Echocardiographic study of carotid arteries</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Disorder Heart</condition>
  <arm_group>
    <arm_group_label>Athletes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>246-km running</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>246-km running</intervention_name>
    <description>Spartathlon 2017</description>
    <arm_group_label>Athletes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Runners at least 18 years old, healthy and sufficiently trained.

          -  Runners being accepted to participate in the Spartathlon race according to the
             eligibility criteria (http://www.spartathlon.gr/en/registration-en.html)

          -  Runners who will volunteer to be examined pre- and post the race

        Exclusion Criteria:

          -  Runners with chronic diseases

          -  Runners receiving any medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evangelia Kouidi, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aristotle University of Thessaloniki, Greece</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratory of Sports Medicine</name>
      <address>
        <city>Thessaloniki</city>
        <zip>546 35</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Seedhouse EL, Walsh ML, Blaber AP. Heart rate, mean arterial blood pressure, and pulmonary function changes associated with an ultraendurance triathlon. Wilderness Environ Med. 2006 Winter;17(4):240-5.</citation>
    <PMID>17219787</PMID>
  </reference>
  <reference>
    <citation>Millet GP, Millet GY. Ultramarathon is an outstanding model for the study of adaptive responses to extreme load and stress. BMC Med. 2012 Jul 19;10:77. doi: 10.1186/1741-7015-10-77.</citation>
    <PMID>22812424</PMID>
  </reference>
  <reference>
    <citation>Cote AT, Phillips AA, Foulds HJ, Charlesworth SA, Bredin SS, Burr JF, Koehle MS, Warburton DE. Sex differences in cardiac function after prolonged strenuous exercise. Clin J Sport Med. 2015 May;25(3):276-83. doi: 10.1097/JSM.0000000000000130.</citation>
    <PMID>25010150</PMID>
  </reference>
  <reference>
    <citation>Jee H, Park J, Oh JG, Lee YH, Shin KA, Kim YJ. Effect of a prolonged endurance marathon on vascular endothelial and inflammation markers in runners with exercise-induced hypertension. Am J Phys Med Rehabil. 2013 Jun;92(6):513-22. doi: 10.1097/PHM.0b013e31829232db.</citation>
    <PMID>23685440</PMID>
  </reference>
  <results_reference>
    <citation>Blaber AP, Walsh ML, Carter JB, Seedhouse EL, Walker VE. Cardiopulmonary physiology and responses of ultramarathon athletes to prolonged exercise. Can J Appl Physiol. 2004 Oct;29(5):544-63.</citation>
    <PMID>15507692</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2017</study_first_submitted>
  <study_first_submitted_qc>October 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2017</study_first_posted>
  <last_update_submitted>October 6, 2017</last_update_submitted>
  <last_update_submitted_qc>October 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>Evangelia Kouidi</investigator_full_name>
    <investigator_title>Cardiologist, Professor of Sports Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No personal details will be shared. Only the results of the measurements will be available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

